Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing mycophenolate mofetil to azathioprine in treatment-naive autoimmune hepatitis is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azathioprine (azathioprine)
  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Autoimmune Hepatitis | Phase 4 | Status: UNKNOWN